Review of Extended-Release Formulations of Tramadol for the Management of Chronic Non-Cancer Pain: Focus on Marketed Formulations

Journal of Pain Research - New Zealand
doi 10.2147/jpr.s49502
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Tapentadol Extended-Release for Treatment of Chronic Pain: A Review

Journal of Pain Research
AnesthesiologyPain Medicine
2011English

Assessment of Dissolution Profile of Marketed Aceclofenac Formulations

Journal of Young Pharmacists
ToxicologyPharmaceuticsPharmacology
2010English

Column Generation for Extended Formulations

EURO Journal on Computational Optimization
ControlSimulationManagement ScienceOptimizationModelingComputational MathematicsOperations Research
2013English

Patient Expectations for Management of Chronic Non-Cancer Pain: A Systematic Review

Health Expectations
EnvironmentalPublic HealthOccupational Health
2016English

Brief Review: Perioperative Management of the Patient With Chronic Non-Cancer Pain

Canadian Journal of Anaesthesia
MedicineAnesthesiologyPain Medicine
2006English

Development of Controlled Release Formulations of Thiabendazole

Journal of Agricultural Chemistry and Environment
2014English

Cost-Effectiveness Analysis of Oral Fentanyl Formulations for Breakthrough Cancer Pain Treatment

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2016English

Pharmacokinetic Simulations of Topiramate Plasma Concentrations Following Dosing Irregularities With Extended-Release vs. Immediate-Release Formulations

Epilepsy and Behavior
NeurologyBehavioral Neuroscience
2015English

Chronic Pain Impact Factors: A Review of the Different Aspects of Chronic Non Cancer Pain

Journal of Psychology & Psychotherapy
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy